文献速递帕金森病与运动障碍

肉毒神经毒素治疗喉部肌张力障碍的中枢短期与长期作用

Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia.
PubMed 文献 · Neurology · 2022-06-28

本研究为功能MRI研究,共纳入161名参与者,旨在探究肉毒神经毒素(BoNT)注射对喉部肌张力障碍(LD)患者脑功能的短期与长期影响。结果显示,治疗获益的LD患者左侧楔前叶活动较未治疗及治疗未获益患者降低;不同亚型活动改变区域不同;治疗6-12年的患者右侧小脑及前额叶皮层活动较其他 duration 组降低。

要点

  • 治疗获益的LD患者左侧楔前叶活动较未治疗及未获益患者降低。
  • 内收型LD治疗者右侧丘脑活动降低,外展型治疗者左侧额下回皮层活动降低。
  • 治疗6-12年患者右侧小脑活动较1-5年及13-28年组降低,右侧前额叶皮层较1-5年组降低。

核心结论

  • 左侧楔前叶是BoNT对LD短期中枢作用的部位,而前额叶-小脑轴参与治疗6-12年患者的中枢反应。
  • 这些结构的参与提示BoNT通过调节运动序列规划和协调间接作用于肌张力障碍感觉运动网络。

研究设计与样本

  • 功能MRI研究,共纳入161名参与者。
  • 统计分析按治疗效果和疗程对LD患者分层,考察BoNT的中枢效应。

主要发现

  • 治疗并获益的LD患者左侧楔前叶活动较未治疗及治疗未获益患者降低。
  • 治疗的内收型LD患者右侧丘脑活动降低,治疗的外展型LD患者左侧额下回皮层活动降低。
  • 疗程较短(1-5年)与较长(13-28年)患者间脑活动无统计学显著差异。
  • 疗程6-12年的患者右侧小脑活动较1-5年及13-28年组降低,右侧前额叶皮层活动较1-5年组降低。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Laryngeal dystonia (LD) is isolated task-specific focal dystonia selectively impairing speech production. The first choice of LD treatment is botulinum neurotoxin (BoNT) injections into the affected laryngeal muscles. However, whether BoNT has a lasting therapeutic effect on disorder pathophysiology is unknown. We investigated short-term and long-term effects of BoNT treatment on brain function in patients with LD. METHODS: A total of 161 participants were included in the functional MRI study. Statistical analyses examined central BoNT effects in patients with LD who were stratified based on the effectiveness and duration of treatment. RESULTS: Patients with LD who were treated and benefited from BoNT injections had reduced activity in the left precuneus compared with BoNT-naive and treatment nonbenefiting patients. In addition, BoNT-treated patients with adductor LD had decreased activity in the right thalamus, whereas BoNT-treated abductor patients with LD had reduced activity in the left inferior frontal cortex. No statistically significant differences in brain activity were found between patients with shorter (1-5 years) and longer (13-28 years) treatment durations. However, patients with intermediate treatment duration of 6-12 years showed reduced activity in the right cerebellum compared with patients with both shorter and longer treatment durations and reduced activity in the right prefrontal cortex compared with patients with shorter treatment duration. DISCUSSION: Our findings suggest that the left precuneus is the site of short-term BoNT central action in patients with LD, whereas the prefrontal-cerebellar axis is engaged in the BoNT response in patients with intermediate treatment duration of 6-12 years. Involvement of these structures points to indirect action of BoNT treatment on the dystonic sensorimotor network through modulation of motor sequence planning and coordination.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. O'Flynn LC, Simonyan K. Short- and Long-term Central Action of Botulinum Neurotoxin Treatment in Laryngeal Dystonia. Neurology. 2022. PMID: 35764404. doi:10.1212/WNL.0000000000200850

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。